Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes
- PMID: 18544706
- PMCID: PMC2518500
- DOI: 10.2337/db08-0332
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes
Abstract
Objective: Poor glycemic control, elevated triglycerides, and albuminuria are associated with vascular complications in diabetes. However, few studies have investigated combined associations between metabolic markers, diabetic kidney disease, retinopathy, hypertension, obesity, and mortality. Here, the goal was to reveal previously undetected association patterns between clinical diagnoses and biochemistry in the FinnDiane dataset.
Research design and methods: At baseline, clinical records, serum, and 24-h urine samples of 2,173 men and 2,024 women with type 1 diabetes were collected. The data were analyzed by the self-organizing map, which is an unsupervised pattern recognition algorithm that produces a two-dimensional layout of the patients based on their multivariate biochemical profiles. At follow-up, the results were compared against all-cause mortality during 6.5 years (295 deaths).
Results: The highest mortality was associated with advanced kidney disease. Other risk factors included 1) a profile of insulin resistance, abdominal obesity, high cholesterol, triglycerides, and low HDL(2) cholesterol, and 2) high adiponectin and high LDL cholesterol for older patients. The highest population-adjusted risk of death was 10.1-fold (95% CI 7.3-13.1) for men and 10.7-fold (7.9-13.7) for women. Nonsignificant risk was observed for a profile with good glycemic control and high HDL(2) cholesterol and for a low cholesterol profile with a short diabetes duration.
Conclusions: The self-organizing map analysis enabled detailed risk estimates, described the associations between known risk factors and complications, and uncovered statistical patterns difficult to detect by classical methods. The results also suggest that diabetes per se, without an adverse metabolic phenotype, does not contribute to increased mortality.
Figures
References
-
- Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C: Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294 :1782 –1787,2005 - PubMed
-
- Morrish N, Wang S, Stevens L, Fuller J, Keen H, the WHO Multinational Study Group: Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 44 :S14 –S21,2001 - PubMed
-
- Gross J, de Azevedo M, Silveiro S, Canani L, Caramori M, Zelmanovitz T: Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28 :164 –176,2005 - PubMed
-
- Newman D, Mattock M, Dawnay A, Kerry S, McGuire A, Yaqoob M, Hitman G, Hawke C: Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess 9 :iii –vi, xiii–163,2005 - PubMed
-
- Soedamah-Muthu S, Chaturvedi N, Toeller M, Ferriss B, Reboldi P, Michel G, Manes C, Fuller J: EURODIAB Prospective Complications Study Group risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27 :530 –537,2004 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
